Patents by Inventor SAMUEL DESJARDINS

SAMUEL DESJARDINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20230183238
    Abstract: Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
    Type: Application
    Filed: February 3, 2023
    Publication date: June 15, 2023
    Inventors: Pavel Osten, Kristin K. Baldwin, Robert DeVita, Samuel Desjardins, Jeffrey Albert
  • Modular synthesis of aminoglycosides
    Patent number: 11673907
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: June 13, 2023
    Assignee: Revagenix, Inc.
    Inventors: Andrew Calabrese, Timothy Robert Kane, Darin Hildebrandt, Michael Lopez, Nikolai Evdokimov, Frederick Cohen, Malken Bayrakdarian, Sanjia Xu, Samuel Desjardins, Olivier Soueidan
  • MODULAR SYNTHESIS OF AMINOGLYCOSIDES
    Publication number: 20230167148
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 1, 2023
    Inventors: Andrew Antony Calabrese, Timothy Robert Kane, Darin Hildebrandt, Michael Lopez, Nikolai Evdokimov, Frederick Cohen, Malken Bayrakdarian, Sanijia Xu, Samuel Desjardins, Olivier Soueidan
  • Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders
    Patent number: 11597726
    Abstract: Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: March 7, 2023
    Assignee: Certego Therapeutics Inc.
    Inventors: Pavel Osten, Kristin K. Baldwin, Robert DeVita, Samuel Desjardins, Jeffrey Albert
  • MODULAR SYNTHESIS OF AMINOGLYCOSIDES
    Publication number: 20220411456
    Abstract: The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.
    Type: Application
    Filed: August 24, 2018
    Publication date: December 29, 2022
    Applicant: Revagenix, Inc.
    Inventors: Andrew CALABRESE, Timothy Robort KANE, Darin HILDEBRANDT, Michael LOPEZ, Nikolai EVDOKIMOV, Frederick COHEN, Malken BAYRAKDARIAN, Sanijia XU, Samuel DESJARDINS, Olivier SOUEIDAN
  • REDOX-SENSITIVE VESICLES
    Publication number: 20180016289
    Abstract: There is provided a redox-sensitive compound comprising a redox-sensitive organometallic moiety and a phospholipid or modified-phospholipid moiety. The compound is embodied in a redox-sensitive drug delivery system. In preferred embodiments, the system comprises redox active giant unilamellar vesicles (GUVs), which are used as drug delivery vessels.
    Type: Application
    Filed: January 19, 2016
    Publication date: January 18, 2018
    Inventors: JANINE MAUZEROLL, TOMER AHARON MOYHOUZER, MICHAEL EDWARD SNOWDEN, PHILIPPE DAUPHIN DUCHARME, STEPHANI MAZURKIEWICZ, CHLOÉ L'HOMME, SAMUEL DESJARDINS, SYLVAIN CANESI